Cargando…
Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy
There has previously been a report of a patient developing haemolytic anaemia following exposure to cefoperazone. Another case has been reported involving the detection of cefoperazone-dependent antibodies in the absence of immune haemolytic anaemia. To date, no serological evidence has been reporte...
Autores principales: | Wu, Yuanjun, Wu, Yong, Ji, Yanli, Liang, Jiajie, He, Ziyi, Liu, Yanhui, Tang, Li, Guo, Ganping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415779/ https://www.ncbi.nlm.nih.gov/pubmed/34485334 http://dx.doi.org/10.3389/fmed.2021.697192 |
Ejemplares similares
-
Comparison of antibiotic-associated diarrhea caused by
cefoperazone/sulbactam or piperacillin/tazobactam in neurosurgery
patients
por: Chen, Yue, et al.
Publicado: (2021) -
Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia
por: He, Xiaoyan, et al.
Publicado: (2023) -
Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation
por: Wang, Xueting, et al.
Publicado: (2023) -
Cefoperazone/sulbactam-induced hemolytic anemia
por: Sun, XM, et al.
Publicado: (2023) -
The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia
por: Lai, Chih-Cheng, et al.
Publicado: (2023)